Derivatives and Hedging Activities - Schedule of Pre-tax Effect of Cash Flow Hedges, Net Investment Hedges and Fair Value Hedges on the Consolidated Statements of Operations, Recorded in Interest and Other Financing Expense, Net (Details) - Reclassification out of Accumulated Other Comprehensive Income - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		$ 1,540	$ 4,434	$ 3,600	$ 6,305
Interest Rate Swap | Cash Flow Hedging | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] | Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		1,011	1,840	2,351	4,176
Cross-currency swaps | Cash Flow Hedging | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] | Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		0	0	0	0
Cross-currency swaps | Fair Value Hedging | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net	[1]	91	2,099	229	1,140
Cross-currency swaps | Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		484	495	968	989
Foreign currency forward contracts | Cash Flow Hedging | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] | Cost of Sales
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		$ (46)	$ 0	$ 52	$ 0

[1] Net of amount that is excluded from effectiveness testing. The amount of gain, excluded from effectiveness testing, reclassified from AOCL into income for the three months ended December 31, 2025 and 2024 was $111 and $123, respectively. The amount of gain, excluded from effectiveness testing, which was reclassified from AOCL into income for the six months ended December 31, 2025 and 2024 was $222 and $247, respectively.